Franz Nothelfer Consultant

Franz Nothelfer is consultant for downstream processing and viral safety. Before his retirement in 2017, he was heading a position as associate director Protein Science at Boehringer Ingelheim Pharma (BI), responsible for the development of novel purification processes for therapeutic proteins and monoclonal antibodies. A major task of his team was the transfer, establishment and optimization of purification processes of customers to achieve robust and economic manufacturing processes. Franz started his career in 1971 at Dr. Karl Thomae GmbH (later BI). In 1979 he joined the newly founded iotechnology department and was involved in the first process transfer of a recombinant protein to BI in 1985. During his career at Boehringer Ingelheim he took over several challenging positions.